Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Migraine symbols : GLAXF save search
Migraine drugs market in Latin America 2023-2027: 5-Year (2017-2021) historic industry size and analysis of 15 vendors and 7 countries - Technavio
Published: 2022-12-06 (Crawled : 02:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 620K
|
n/a
|
| O: -2.59%
H: 4.21%
C: 2.0%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 2.04%
H: 8.0%
C: 7.71%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.74%
H: 8.46%
C: 8.46%
IGXT | $0.16 -19.77% 47K
|
Manufacturing
|
| O: -6.33%
H: 9.38%
C: 7.52%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -1.19%
H: 14.39%
C: 9.15%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.05%
H: 0.22%
C: -0.19%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.33%
H: 0.56%
C: -0.89%
america migraine market
The Global Migraine Drugs Market is expected to grow by $1 bn during 2022-2026, accelerating at a CAGR of 5.74% during the forecast period
Published: 2022-11-21 (Crawled : 16:00) - prnewswire.com
ENDPQ | $0.0006 -50.0% 620K
|
n/a
|
| O: -1.63%
H: 3.73%
C: 3.63%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 3.09%
H: 0.0%
C: -1.59%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.74%
H: 0.89%
C: 0.53%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 2.04%
H: 0.06%
C: -0.36%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.27%
H: 2.08%
C: 1.1%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -0.13%
H: 1.13%
C: 0.14%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.02%
H: 0.0%
C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.68%
H: 0.35%
C: -0.12%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.63%
H: 0.87%
C: -0.32%
global expected migraine market
Migraine Therapeutics Market Report 2021: Featuring Major Vendors including AbbVie Inc., Amgen Inc. & Eli Lilly and Co.- Technavio
Published: 2022-07-13 (Crawled : 11:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.1%
H: 0.05%
C: -1.41%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -1.62%
H: 0.83%
C: 0.37%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.98%
H: 1.2%
C: 0.1%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.24%
H: 0.97%
C: 0.29%
report therapeutics migraine market
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.